Several biologics, such as the anti-tumor necrosis factor alpha (TNF- α) antibody, anti-α4β7 antibody, interleukin (IL) 12/23 antibody, and Janus kinase inhibitor, have recently been developed and used in IBD treatment. Here, TNF is linked to inflammatory bowel disease.